Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Nov 20;10(11):978.
doi: 10.3390/diagnostics10110978.

The Diagnostic Performance of Interleukin-6 and C-Reactive Protein for Early Identification of Neonatal Sepsis

Affiliations

The Diagnostic Performance of Interleukin-6 and C-Reactive Protein for Early Identification of Neonatal Sepsis

Belay Tessema et al. Diagnostics (Basel). .

Abstract

Interleukin-6 (IL-6) and C-reactive protein (CRP) are being used for diagnosis of sepsis. However, studies have reported varying cut-off levels and diagnostic performance. This study aims to investigate the optimal cut-off levels and performance of IL-6 and CRP for the diagnosis of neonatal sepsis. The study was conducted at the University Hospital of Leipzig, Germany from November 2012 to June 2020. A total of 899 neonates: 104 culture proven sepsis, 160 clinical sepsis, and 625 controls were included. Blood culture was performed using BacT/ALERT 3D system. IL-6 and CRP were analyzed by electrochemiluminescent immunoassay and immunoturbidimetric assay, respectively. Data were analyzed using SPSS 20 statistical software. Among neonates with proven sepsis, the optimal cut-off value of IL-6 was 313.5 pg/mL. The optimal cut-off values for CRP in 5 days serial measurements (CRP1, CRP2, CRP3, CRP4, and CRP5) were 2.15 mg/L, 8.01 mg/L, 6.80 mg/L, 5.25 mg/L, and 3.72 mg/L, respectively. IL-6 showed 73.1% sensitivity, 80.2% specificity, 37.6% PPV, and 94.8% NPV. The highest performance of CRP was observed in the second day with 89.4% sensitivity, 97.3% specificity, 94.5% PPV, and 98.3% NPV. The combination of IL-6 and CRP showed increase in sensitivity with decrease in specificity. In conclusion, this study defines the optimal cut-off values for IL-6 and CRP. The combination of IL-6 and CRP demonstrated increased sensitivity. The CRP 2 at cut-off 8.01 mg/L showed the highest diagnostic performance for identification of culture negative clinical sepsis cases. We recommend the combination of IL-6 (≥313.5 pg/mL) and CRP1 (≥2.15 mg/L) or IL-6 (≥313.5 pg/mL) and CRP2 (≥8.01 mg/L) for early and accurate diagnosis of neonatal sepsis. The recommendation is based on increased sensitivity, that is, to minimize the risk of any missing cases of sepsis. The CRP2 alone at cut-off 8.01 mg/L might be used to identify clinical sepsis cases among culture negative sepsis suspected neonates in hospital settings.

Keywords: C-reactive protein; diagnosis; interleukin-6; neonatal sepsis.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The receiver operating characteristic (ROC) curves for IL-6 and CRP tests drawn from sensitivity versus 1-specificity using culture proven sepsis cases and controls. ROC shows the performance of a test at all classification thresholds. AUC = area under the ROC curve. AUC provides an aggregate measure of performance of a test across all possible classification thresholds. AUC indicates the accuracy of IL-6 or CRP to correctly classify sepsis cases from controls. An AUC of 1 represents a perfect test; 0.90–1 = excellent, 0.80–0.90 = good; 0.70–0.80 = fair; 0.60–0.70 = poor; 0.50–0.60 = fail and an AUC of 0.5 represents a worthless test. CI = Confidence interval.

Similar articles

Cited by

References

    1. Hofer N., Zacharias E., Müller W., Resch B. An Update on the Use of C-Reactive Protein in Early-Onset Neonatal Sepsis: Current Insights and New Tasks. Neonatology. 2012;102:25–36. doi: 10.1159/000336629. - DOI - PubMed
    1. Barnett E.D., Klein J.O. In: Infectious Diseases of the Fetus and Newborn. 6th ed. Remington J.S., Klein J.O., editors. Elsevier Health Sciences; Philadelphia, PA, USA: 2011.
    1. Lemons J.A., Bauer C.R., Oh W., Korones S.B., Papile L.-A., Stoll B.J., Verter J., Temprosa M., Wright L.L., Ehrenkranz R.A., et al. Very Low Birth Weight Outcomes of the National Institute of Child Health and Human Development Neonatal Research Network, January 1995 through December 1996. Pediatrics. 2001;107:e1. doi: 10.1542/peds.107.1.e1. - DOI - PubMed
    1. Gladstone I.M., Ehrenkranz R.A., Edberg S.C., Baltimore R.S. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr. Infect. Dis. J. 1990;9:819–890. doi: 10.1097/00006454-199011000-00009. - DOI - PubMed
    1. Calil R., Marba S.T.M., Von Nowakonski A., Tresoldi A.T. Reduction in colonization and nosocomial infection by multiresistant bacteria in a neonatal unit after institution of educational measures and restriction in the use of cephalosporins. Am. J. Infect. Control. 2001;29:133–138. doi: 10.1067/mic.2001.114223. - DOI - PubMed